The university, one of the continental centers of excellence, has developed a world patent for the new biological aspirin - based on herbs and oil - without a cent of public funds but only with the sweat of researchers from the university and Rethymnon Agricultural cooperative. Meanwhile, anticancer drugs and HIV drugs are nowhere to be found
by Francesco De Palo | March 9, 2013 |
What better occasion than the crisis and infinite material constraints to produce new ideas and low cost solutions? The University of Crete, one of the continental centers of excellence, has developed a world patent for the new biological aspirin, without a cent of public funds but only with the sweat of researchers from the university and the Rethymnon Agricultural Cooperative. Pending the necessary certification by the EMEA and the FDA (the competent US and European authorities), it could be placed on the market as early as this year at the competitive price of one euro. The new organic aspirin bears the signature of Crete and a very ancient recipe, based on the mix of three herbs that grow on the island of the Minotaur, dissolved in the fine local olive oil. The capsule was born from the experiments conducted by a group of scientists from the University of Crete, who combine the maximum exploitation of Cretan herbs with the rigorous standards set by modern medical science. The promoters of this initiative are Professor Elia Kastanas and Xristos Lionis, professor of Biology who were able to count on the logistical support of the Rethymnon rural cooperative and the pharmaceutical Gallenica.
From the entourage of the university they let it be known that the most interesting fact of this operation is that Cretan aspirin could potentially be able to cross the country's commercial borders, thus going beyond the "Hellenic crisis" basin, where the he whole pharmaceutical sector is going through dramatic years, with 60% of scientific representatives left without work, with very serious cases of unobtainable drugs (anti-tumor and for HIV patients) and with numerous pharmacies forced to close (one hundred in 2012) because expectation of the millionaire credits accrued by the state.
In addition, the real success of the new capsule lies in the fact that the ingredients necessary for its production are completely natural. But be careful not to confuse it with a food supplement, they are keen to specify. And they observe that the purpose of their science is not to replace or confuse traditional aspirin, but to
